United States · FDA National Drug Code directory
Pioglitazone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-056_7d118937-d5b2-402f-8e24-f70a48c1d432
- Product NDC
- 33342-056
- Form
- TABLET
- Composition / generic term
- Pioglitazone
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130214
- Source listing expiry
- 20261231
Source-listed ingredients
- PIOGLITAZONE HYDROCHLORIDE — 45 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (33342-056-07) · 33342-056-07
- 90 TABLET in 1 BOTTLE (33342-056-10) · 33342-056-10
- 100 TABLET in 1 BOX, UNIT-DOSE (33342-056-12) · 33342-056-12
- 500 TABLET in 1 BOTTLE (33342-056-15) · 33342-056-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →